NASDAQ:ANGO AngioDynamics (ANGO) Stock Price, News & Analysis $15.54 +0.05 (+0.32%) Closing price 09/28/2026 04:00 PM EasternExtended Trading$15.44 -0.10 (-0.64%) As of 09/28/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About AngioDynamics Stock (NASDAQ:ANGO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get AngioDynamics alerts:Sign Up Key Stats Today's Range$15.20▼$15.7650-Day Range$13.44▼$16.1352-Week Range$9.39▼$16.29Volume495,606 shsAverage Volume434,918 shsMarket Capitalization$642.27 millionP/E RatioN/ADividend YieldN/APrice Target$19.50Consensus RatingHold Company Overview AngioDynamics, Inc. (NASDAQ: ANGO) is a medical technology company that develops and manufactures minimally invasive devices used in vascular, oncology, and surgical procedures. Its products are designed to help physicians diagnose and treat vascular disease, remove or manage blood clots, and deliver targeted therapies for certain cancers and other conditions. The company’s product portfolio includes the Auryon Atherectomy System for treating peripheral arterial disease, the AngioVac System for the removal of unwanted intravascular material, and the NanoKnife System, which uses irreversible electroporation to ablate soft-tissue tumors. AngioDynamics also offers devices for vascular access and other interventional procedures, including systems intended to support catheter placement and reduce complications. Founded in 1988 and headquartered in Latham, New York, AngioDynamics sells its products through a combination of direct sales and distributors in the United States and international markets. The company serves hospitals, physicians, and other healthcare providers, with an emphasis on technologies that can be used in less invasive alternatives to traditional surgery.AI Generated. May Contain Errors. Read More AngioDynamics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks71st Percentile Overall ScoreANGO MarketRank™: AngioDynamics scored higher than 71% of companies evaluated by MarketBeat, and ranked 215th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.0 / 5Analyst RatingHold Consensus RatingAngioDynamics has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 1 strong buy rating, 2 buy ratings, no hold ratings, and 2 sell ratings.Upside PotentialAngioDynamics has a consensus price target of $19.50, representing about 25.5% upside from its current price of $15.54.Amount of Analyst CoverageAngioDynamics has only been the subject of 4 research reports in the past 90 days.Read more about AngioDynamics' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for AngioDynamics are expected to grow in the coming year, from ($0.25) to ($0.17) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AngioDynamics is -17.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AngioDynamics is -17.86, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAngioDynamics has a P/B Ratio of 3.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about AngioDynamics' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.46% of the float of AngioDynamics has been sold short.Short Interest Ratio / Days to CoverAngioDynamics has a short interest ratio ("days to cover") of 3.48, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in AngioDynamics has recently decreased by 1.48%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAngioDynamics does not currently pay a dividend.Dividend GrowthAngioDynamics does not have a long track record of dividend growth. News and Social Media2.3 / 5News Sentiment0.75 News SentimentAngioDynamics has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for AngioDynamics this week, compared to 4 articles on an average week.Search InterestOnly 1 people have searched for ANGO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added AngioDynamics to their MarketBeat watchlist in the last 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, AngioDynamics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $344,006.00 in company stock.Percentage Held by Insiders6.00% of the stock of AngioDynamics is held by insiders.Percentage Held by Institutions89.43% of the stock of AngioDynamics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about AngioDynamics' insider trading history. Receive ANGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ANGO Stock News HeadlinesAngioDynamics to Report Fiscal 2027 First Quarter Results on October 8, 2026September 28 at 5:00 PM | businesswire.comAngioDynamics (ANGO) Expected to Post Quarterly Earnings on ThursdaySeptember 24, 2026 | americanbankingnews.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required. | Chaikin Analytics (Ad)AngioDynamics, Inc. (NASDAQ:ANGO) Given Average Recommendation of "Hold" by BrokeragesSeptember 20, 2026 | americanbankingnews.comAngioDynamics, Inc. (ANGO) Presents at Canaccord Genuity's 46th Annual Growth Conference - SlideshowAugust 11, 2026 | seekingalpha.comTop AngioDynamics Executive Makes Bold Move With Major Stock SaleJuly 31, 2026 | tipranks.comAngioDynamics to Participate in Upcoming Investor ConferencesJuly 28, 2026 | businesswire.comAngioDynamics (ANGO) Q4 2026 Earnings Call TranscriptJuly 22, 2026 | finance.yahoo.comSee More Headlines ANGO Stock Analysis - Frequently Asked Questions How have ANGO shares performed this year? AngioDynamics' stock was trading at $12.84 at the beginning of 2026. Since then, ANGO stock has increased by 21.0% and is now trading at $15.54. How were AngioDynamics' earnings last quarter? AngioDynamics, Inc. (NASDAQ:ANGO) posted its quarterly earnings data on Tuesday, July, 14th. The medical instruments supplier reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.11) by $0.04. The medical instruments supplier earned $86.61 million during the quarter, compared to analysts' expectations of $80.24 million. AngioDynamics had a negative trailing twelve-month return on equity of 5.73% and a negative net margin of 11.48%. Read the conference call transcript. Does AngioDynamics have any subsidiaries? The following companies are subsidiaries of AngioDynamics: Eximo Medical Ltd., RadiaDyne LLC, Clinical Devices, Vortex Medical, Navilyst Medical Inc., FlowMedica, Oncovionic, and more. How do I buy shares of AngioDynamics? Shares of ANGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of AngioDynamics own? Based on aggregate information from My MarketBeat watchlists, some other companies that AngioDynamics investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings7/14/2026Today9/28/2026Next Earnings (Estimated)10/01/2026Fiscal Year End5/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 ANGO's financial health is in the Green zone, according to TradeSmith. ANGO has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:ANGO CIK1275187 Webwww.angiodynamics.com Phone(518) 795-1400Fax518-795-1401Employees632Year Founded1988Price Target and Rating Average Price Target for AngioDynamics$19.50 High Price Target$20.00 Low Price Target$19.00 Potential Upside/Downside+25.5%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.87) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$36.74 million Net Margins-11.48% Pretax Margin-11.34% Return on Equity-5.73% Return on Assets-3.77% Debt Debt-to-Equity RatioN/A Current Ratio2.19 Quick Ratio1.49 Sales & Book Value Annual Sales$320.17 million Price / Sales2.01 Cash Flow$0.31 per share Price / Cash Flow49.51 Book Value$4.13 per share Price / Book3.76Miscellaneous Outstanding Shares41,330,000Free Float38,852,000Market Cap$642.27 million OptionableOptionable Beta0.33 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:ANGO) was last updated on 9/29/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
